Sector ratings Laboratorios Farmaceuticos Rovi, S.A.

Stocks

Delayed BME 07:04:59 2026-08-17 am EDT			5-day change	1st Jan Change
57.65 ^EUR	-0.52%		-1.79%	-9.21%

Jul. 23	Laboratorios Farmaceuticos Rovi, S.A., H1 2026 Earnings Call, Jul 23, 2026
Jul. 23	Laboratorios Farmaceuticos Rovi, S.A. Reports Earnings Results for the Half Year Ended June 30, 2026	CI

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Global Valuation
LABORATORIOS FARMACEUTICOS ROVI, S.A.	3.43B		BBB
ELI LILLY AND COMPANY	1,052B		A
JOHNSON & JOHNSON	627B	-	BBB	-	-
ABBVIE INC.	441B		AA		-
ROCHE HOLDING AG	349B		AA
NOVARTIS AG	287B		AAA
ASTRAZENECA PLC	241B		A
AMGEN INC.	224B		A
NOVO NORDISK A/S	202B		A
GILEAD SCIENCES, INC.	172B		AA
PFIZER INC.	153B		A
BRISTOL-MYERS SQUIBB COMPANY	130B		A
VERTEX PHARMACEUTICALS INCORPORATED	128B		AA
SANOFI	105B		AA
GSK PLC	98.67B		AA
CHUGAI PHARMACEUTICAL CO., LTD.	71.68B		AA
TAKEDA PHARMACEUTICAL COMPANY LIMITED	56.3B		AA
BAYER AG	54.36B		AA
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	51.37B		AA
TEVA PHARMACEUTICAL INDUSTRIES LIMITED	42.85B		-
Average	224.49B		AA
Weighted average by Cap.			AA